Skip to content
OpenCapital
Get started

Imax IMAX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB
——

Other financials

Income statement

See full
Revenue$81.4M-6.1%
Gross profit$45.8M-13.9%
Operating income$10.0M-40.5%
Net income$4.2M+81.6%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$146.0M+50.4%
Total debt$11.1M-6.7%
Total equity$335.5M+12.0%
Total assets$893.2M+5.3%

Cash flow

See full
Operating cash flow$4.0M-42.0%
CapEx$2.1M+29.6%
Free cash flow$1.9M-64.2%

Valuation

See full
Market cap$2.47B+46.9%
P/E67.3×+0.2×
P/S6.1×+1.4×

Profitability

See full
Gross margin59%+4.4pp
Operating margin19.1%+5.6pp
Net margin9.1%+2.1pp
FCF margin28.5%+6.3pp

Returns & leverage

See full
Return on equity11.6%+2.6pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Imax (IMAX) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $25.42 in Q1 2026.
How has Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price decreased by 0.7% year-over-year, from $25.59 to $25.42.
What is the long-term trend for Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Imax's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a -0.8% compound annual growth rate (CAGR), from $26.61 to $25.82.